Immunotherapy has transformed cancer treatment by harnessing the body’s natural defenses to target and destroy cancer cells. However, evaluating its effectiveness presents unique challenges. Imaging is crucial—not only for monitoring tumor response and detecting distinctive patterns like pseudoprogression, but also… Read More
Radiopharmaceutical therapies (RPTs) are transforming cancer treatment by combining radiation with targeted drug delivery. These therapies require a delicate balance between effectiveness and safety, especially considering the unique long-term risks of radiation exposure. The FDA recently released a draft guidance… Read More
Gliomas are the most common type of malignant primary brain tumor. Imaging is crucial in diagnosing gliomas and evaluating treatment responses. Proper application and customization of the RANO and RAPNO criteria for each unique clinical trial, including criteria clarifications and… Read More
Imaging is vital for diagnosing, staging, and monitoring multiple myeloma (MM) in clinical trials. Common imaging methods include Whole-Body Low-Dose CT, ideal for initial MM-related lytic bone lesion assessment; MRI, the gold standard for detecting bone marrow involvement; and 18F-FDG… Read More
Colorectal cancer (CRC) is the third most frequent cancer diagnosed in the world, and the second most frequent cause of death related to cancer. Imaging has a critical role in diagnosis, determining stage of the disease, selecting treatment strategies, and… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
